HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: Implications for AIDS-associated vasculopathy

Virus Research

Volumn 104, Issue 2, 2004, Pages 145-155

  Matzen, Kathrin ^a   Dirkx, Anita E M ^b   Oude Egbrink, Mirjam G A ^c   Speth, Cornelia ^d   Götte, Matthias ^e   Ascherl, Gudrun ^a   Grimm, Thomas ^a   Griffioen, Arjan W ^b   Stürzl, Michael ^a,f  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d UNIVERSITY OF INNSBRUCK   (Austria)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

AIDS; Cytokines; HIV 1 Tat; Monocytes macrophages; T lymphocytes

Indexed keywords

CYTOKINE; ENVELOPE PROTEIN; NEF PROTEIN; REGULATOR PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VIRUS PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANALYTIC METHOD; ANIMAL CELL; ARTICLE; B LYMPHOCYTE; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL ADHESION; CELL FUNCTION; CELL TYPE; CONTROLLED STUDY; ENDOTHELIUM; ENDOTHELIUM CELL; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; LEUKOCYTE; LEUKOCYTE ADHERENCE; MACROPHAGE; MICROSCOPY; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; SERUM; T LYMPHOCYTE; TRANSCRIPTION INITIATION; VASCULAR DISEASE; VIRUS INFECTION;

CELL ADHESION; CELL AGGREGATION; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GENE PRODUCTS, TAT; HIV-1; HUMANS; MONOCYTES; RECEPTORS, CYTOADHESIN; RNA, MESSENGER; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 3042794582     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2004.04.001     Document Type: Article

References (57)

1. Acevedo M., Sprecher D.L., Calabrese L., Pearce G.L., Coyner D.L., Halliburton S.S., White R.D., Sykora E., Kondos G.T., Hoff J.A. Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: 'a call for cardiovascular prevention'. Atherosclerosis. 163(2):2002;349-354
2. Albini A., Barillari G., Benelli R., Gallo R.C., Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. U.S.A. 92:1995;4838-4842
3. Albini A., Soldi R., Giunciuglio D., Giraudo E., Benelli R., Primo L., Noonan D., Salio M., Camussi G., Rockl W., Bussolino F. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells. Nat. Med. 2:1996;1371-1375
4. Albini A., Fontanini G., Masiello L., Tacchetti C., Bigini D., Luzzi P., Noonan D.M., Stetler-Stevenson W.G. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS. 8:1994;1237-1244
5. Arya S.K., Guo C., Josephs S.F., Wong-Staal F. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). Science. 229:1985;69-73
6. Barillari G., Buonaguro L., Fiorelli V., Hoffman J., Michaels F., Gallo R.C., Ensoli B. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol. 149:1992;3727-3734
7. Barillari G., Gendelman R., Gallo R.C., Ensoli B. The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl. Acad. Sci. U.S.A. 90:1993;7941-7945
8. Barillari G., Sgadari C., Fiorelli V., Samaniego F., Colombini S., Manzari V., Modesti A., Nair B.C., Cafaro A., Stürzl M., Ensoli B. The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor. Blood. 94:1999a;663-672
9. Barillari G., Sgadari C., Palladino C., Gendelman R., Caputo A., Morris C.B., Nair B.C., Markham P., Nel A., Stürzl M., Ensoli B. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. J. Immunol. 163:1999b;1929-1935
10. Beral V., Peterman T.A., Berkelman R.L., Jaffe H.W. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection. Lancet. 335:1990;123-128
11. Blasig C., Zietz C., Haar B., Neipel F., Esser S., Brockmeyer N.H., Tschachler E., Colombini S., Ensoli B., Stürzl M. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J. Virol. 71:1997;7963-7968
12. Bonnet F., Morlat P., Chene G., Mercie P., Neau D., Chossat I., Decoin M., Djossou F., Beylot J., Dabis F. Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy, Bordeaux, France, 1998-1999. HIV Med. 3:2002;195-199
13. Chang H.C., Samaniego F., Nair B.C., Buonaguro L., Ensoli B. HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS. 11:1997;1421-1431
14. Chang H.K., Gallo R.C., Ensoli B. Regulation of cellular gene expression and function by the human immunodeficiency virus type 1 tat protein. J. Biomed. Sci. 2:1995;189-202
15. Corallini A., Altavilla G., Pozzi L., Bignozzi F., Negrini M., Rimessi P., Gualandi F., Barbanti-Brodano G. Systemic expression of HIV-1 tat gene in transgenic mice induces endothelial proliferation and tumors of different histotypes. Cancer Res. 53:1993;5569-5575
16. Dhawan S., Puri R.K., Kumar A., Duplan H., Masson J.M., Aggarwal B.B. Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells. Blood. 90:1997;1535-1544
17. Dirkx A.E., Oude Egbrink M.G., Kuijpers M.J., van der Niet S.T., Heijnen V.V., Bouma-ter Steege J.C., Wagstaff J., Griffioen A.W. Tumor angiogenesis modulates leukocyte-vessel wall interactions in vivo by reducing endothelial adhesion molecule expression. Cancer Res. 63:2003;2322-2329
18. Ensoli B., Barillari G., Salahuddin S.Z., Gallo R.C., Wong-Staal F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature. 345:1990;84-86
19. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R.A., Wingfield P., Gallo R.C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol. 67:1993;277-287
20. Ensoli B., Gendelman R., Markham P., Fiorelli V., Colombini S., Raffeld M., Cafaro A., Chang H.K., Brady J.N., Gallo R.C. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature. 371:1994a;674-680
21. Ensoli B., Markham P., Kao V., Barillari G., Fiorelli V., Gendelman R., Raffeld M., Zon G., Gallo R.C. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS. J. Clin. Invest. 94:1994b;1736-1746
22. Ensoli B., Sgadari C., Barillari G., Sirianni M.C., Stürzl M., Monini P. Biology of Kaposi's sarcoma. Eur. J. Cancer. 37:2001;1251-1269
23. Ensoli B., Stürzl M. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 9:1998;63-83
24. Fanales-Belasio E., Moretti S., Nappi F., Barillari G., Micheletti F., Cafaro A., Ensoli B. Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses. J. Immunol. 168:2002;197-206
25. Ferrari A., Pellegrini V., Arcangeli C., Fittipaldi A., Giacca M., Beltram F. Caveolae-mediated internalization of extracellular HIV-1 tat fusion proteins visualized in real time. Mol. Ther. 8:2003;284-294
26. Fiorelli V., Gendelman R., Samaniego F., Markham P.D., Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J. Clin. Invest. 95:1995;1723-1734
27. Fiorelli V., Gendelman R., Sirianni M.C., Chang H.K., Colombini S., Markham P.D., Monini P., Sonnabend J., Pintus A., Gallo R.C., Ensoli B. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection? Blood. 91:1998;956-967
28. Guenzi E., Töpolt K., Cornali E., Lubeseder-Martellato C., Jörg A., Matzen K., Zietz C., Kremmer E., Nappi F., Schwemmle M., Hohenadl C., Barillari G., Tschachler E., Monini P., Ensoli B., Stürzl M. The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. Embo. J. 20:2001;5568-5577
29. Guenzi E., Töpolt K., Lubeseder-Martellato C., Jörg A., Naschberger E., Benelli R., Albini A., Stürzl M. The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. Embo. J. 22:2003;3772-3782
30. Kobayashi S., Hamamoto Y., Kobayashi N., Yamamoto N. Serum level of TNF alpha in HIV-infected individuals. AIDS. 4:1990;169-170
31. Kohleisen B., Gaedigk-Nitschko K., Ohlmann M., Gotz E., Ostolaza H., Goni F.M., Erfle V. Heparin-binding capacity of the HIV-1 NEF-protein allows one-step purification and biochemical characterization. J. Virol. Methods. 60:1996;89-101
32. Kumar A., Manna S.K., Dhawan S., Aggarwal B.B. HIV-Tat protein activates c-Jun N-terminal kinase and activator protein- 1a. J. Immunol. 161:1998;776-781
33. Lafrenie R.M., Wahl L.M., Epstein J.S., Hewlett I.K., Yamada K.M., Dhawan S. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J. Immunol. 156:1996a;1638-1645
34. Lafrenie R.M., Wahl L.M., Epstein J.S., Hewlett I.K., Yamada K.M., Dhawan S. HIV-1-Tat protein promotes chemotaxis and invasive behavior by monocytes. J. Immunol. 157:1996b;974-977
35. Lafrenie R.M., Wahl L.M., Epstein J.S., Yamada K.M., Dhawan S. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. J. Immunol. 159:1997;4077-4083
36. Lahdevirta J., Maury C.P., Teppo A.M., Repo H. Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome. Am. J. Med. 85:1988;289-291
37. MacPhail L.A., Dekker N.P., Regezi J.A. Macrophages and vascular adhesion molecules in oral Kaposi's sarcoma. J. Cutan. Pathol. 23:1996;464-472
38. Medrano F.J., Leal M., Arienti D., Rey C., Zagliani A., Torres Y., Sanchez-Quijano A., Lissen E., Clerici M. Tumor necrosis factor beta and soluble APO-1/Fas independently predict progression to AIDS in HIV-seropositive patients. AIDS Res. Hum. Retroviruses. 14:1998;835-843
39. Mitola S., Sozzani S., Luini W., Primo L., Borsatti A., Weich H., Bussolino F. Tat-human immunodeficiency virus-1 induces human monocyte chemotaxis by activation of vascular endothelial growth factor receptor-1. Blood. 90:1997;1365-1372
40. Nickoloff B.J., Griffiths C.E. The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes. Am. J. Pathol. 135:1989;793-800
41. Pellicelli A.M., Palmieri F., Cicalini S., Petrosillo N. Pathogenesis of HIV-related pulmonary hypertension. Ann. N.Y. Acad. Sci. 946:2001;82-94
42. Pugliese A., Torre D., Saini A., Pagliano G., Gallo G., Pistono P.G., Paggi G.C. Cytokine detection in HIV-1/HHV-8 co-infected subjects. Cell Biochem. Funct. 20:2002;191-194
43. Regezi J.A., MacPhail L.A., Daniels T.E., DeSouza Y.G., Greenspan J.S., Greenspan D. Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells. Am. J. Pathol. 143:1993;240-249
44. Rinaldo C.R. Jr., Armstrong J.A., Kingsley L.A., Zhou S., Ho M. Relation of alpha and gamma interferon levels to development of AIDS in homosexual men. J. Exp. Pathol. 5:1990;127-132
45. Schwarze S.R., Ho A., Vocero-Akbani A., Dowdy S.F. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science. 285:1999;1569-1572
46. Sinicco A., Biglino A., Sciandra M., Forno B., Pollono A.M., Raiteri R., Gioannini P. Cytokine network and acute primary HIV-1 infection. AIDS. 7:1993;1167-1172
47. Speth C., Schabetsberger T., Mohsenipour I., Stockl G., Wurzner R., Stoiber H., Lass-Florl C., Dierich M.P. Mechanism of human immunodeficiency virus-induced complement expression in astrocytes and neurons. J. Virol. 76:2002;3179-3188
48. Stürzl M., Zietz C., Monini P., Ensoli B. Human herpesvirus-8 and Kaposi's sarcoma: relationship with the multistep concept of tumorigenesis. Adv. Cancer Res. 81:2001;125-159
49. Tabata M., Langford A., Becker J., Reichart P.A. Distribution of immunocompetent cells in oral Kaposi's sarcoma (AIDS). Eur. J. Cancer B Oral Oncol. 29B:1993;209-213
50. Tromp S.C., oude Egbrink M.G., Dings R.P., van Velzen S., Slaaf D.W., Hillen H.F., Tangelder G.J., Reneman R.S., Griffioen A.W. Tumor angiogenesis factors reduce leukocyte adhesion in vivo. Int. Immunol. 12:2000;671-676
51. Uccini S., Sirianni M.C., Vincenzi L., Topino S., Stoppacciaro A., Lesnoni La Parola I., Capuano M., Masini C., Cerimele D., Cella M., Lanzavecchia A., Allavena P., Mantovani A., Baroni C.D., Ruco L.P. Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am. J. Pathol. 150:1997;929-938
52. Ullum H., Cozzi Lepri A., Bendtzen K., Victor J., Gotzsche P.C., Phillips A.N., Skinhoj P., Klarlund Pedersen B. Low production of interferon gamma is related to disease progression in HIV infection: evidence from a cohort of 347 HIV-infected individuals. AIDS Res. Hum. Retroviruses. 13:1997;1039-1046
53. Vaishnav Y.N., Wong-Staal F. The biochemistry of AIDS. Annu. Rev. Biochem. 60:1991;577-630
54. Vogel J., Hinrichs S.H., Reynolds R.K., Luciw P.A., Jay G. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature. 335:1988;606-611
55. von Andrian U.H., Chambers J.D., McEvoy L.M., Bargatze R.F., Arfors K.E., Butcher E.C. Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta 2 integrins in vivo. Proc. Natl. Acad. Sci. U.S.A. 88:1991;7538-7542
56. Westendorp M.O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K.M., Krammer P.H. Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120A. Nature. 375:1995;497-500
57. Zietz C., Hotz B., Stürzl M., Rauch E., Penning R., Löhrs U. Aortic endothelium in HIV-1 infection: chronic injury, activation, and increased leukocyte adherence. Am. J. Pathol. 149:1996;1887-1898